NCT06346886 HTN App for HTN Control and Cardiovascular Health Among African-Americans
| NCT ID | NCT06346886 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-05-15 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-05-15 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to test the hypertension (HTN) app-based intervention to see if it is more effective in improving uncontrolled HTN and HTN self-care among Africian-Americans from baseline to post-intervention (immediate, 3 months and 6 months post-intervention) as compared to the standard of care.
Eligibility Criteria
Inclusion Criteria: * African-American (AA) adults that are established patients at Neighborhood HealthSource in Minneapolis, Minnesota. * Receives primary care (i.e., has designated primary care provider) at the partnering FQHCs and intent to continue care there for next 12 months * African American race/ethnicity * Men and women aged ≥18 years * Uncontrolled HTN (defined as Stage 2 HTN with a BP ≥140/90 mmHg \[as per 2017 American College of Cardiology/American Heart Association HTN Guidelines32\] at most recent outpatient evaluation, with or without BP medications) * Documented diagnosis of HTN in EHR * At least 1 office visit at the partnering FQHCs in the prior year * Smartphone ownership (supporting iOS or Android Systems) * Active email address and willingness to utilize it throughout the study * Basic Internet navigation skills (for example, can search for information on websites, open and send emails) * Access to the Internet on at least a weekly basis (such as at home, a family member's or friend's home, church, library/community center, school/university, Internet café, etc.)? Exclusion Criteria: * Diagnosis of a serious medical condition or disability that would make participation difficult (i.e. visual or hearing impairment, mental disability that would preclude independent use of the app). * No primary care provider at partnering FQHC
Contact & Investigator
LaPrincess Brewer, M.D., M.P.H
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06346886 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06346886 currently recruiting?
Yes, NCT06346886 is actively recruiting participants. Contact the research team at Moen.Lainey@mayo.edu for enrollment information.
Where is the NCT06346886 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT06346886 clinical trial?
NCT06346886 is sponsored by Mayo Clinic. The principal investigator is LaPrincess Brewer, M.D., M.P.H at Mayo Clinic. The trial plans to enroll 100 participants.